More specifically, the SP5-52 peptide bound selectively to the vascular endothelial growth factor (VEGF) of human lung cancer surgical specimens, which resulted in tumor homing into eight different types of human tumor xenograft models. This evidence concerns the gene SP5 and neoplasm.